PDCD1 and neoplasm: Both treatments resulted in a higher percentage of tumor fragment death than of the isotype control fragments, with α-CTLA4 yielding a 2.5-fold increase and α-PD-1 yielding a 2.4-fold increase at the last time point taken (Figure 2b).